GHIMENTI, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 5.711
EU - Europa 3.490
AS - Asia 3.117
SA - Sud America 505
AF - Africa 167
OC - Oceania 21
Continente sconosciuto - Info sul continente non disponibili 3
Totale 13.014
Nazione #
US - Stati Uniti d'America 5.541
IT - Italia 1.385
SG - Singapore 990
CN - Cina 956
HK - Hong Kong 479
SE - Svezia 461
DE - Germania 457
BR - Brasile 421
BG - Bulgaria 224
GB - Regno Unito 172
FI - Finlandia 171
VN - Vietnam 159
TR - Turchia 137
CA - Canada 135
FR - Francia 124
RU - Federazione Russa 106
IN - India 105
AT - Austria 101
KR - Corea 81
CI - Costa d'Avorio 71
UA - Ucraina 48
NL - Olanda 40
JP - Giappone 36
PL - Polonia 32
BD - Bangladesh 27
BE - Belgio 23
ES - Italia 23
CH - Svizzera 22
IR - Iran 22
SN - Senegal 22
AR - Argentina 21
GR - Grecia 17
IE - Irlanda 16
MX - Messico 16
AU - Australia 15
UZ - Uzbekistan 15
ZA - Sudafrica 15
ID - Indonesia 14
VE - Venezuela 13
EC - Ecuador 12
CZ - Repubblica Ceca 11
MA - Marocco 11
TW - Taiwan 11
UY - Uruguay 11
CO - Colombia 10
IQ - Iraq 9
PH - Filippine 9
PK - Pakistan 9
EG - Egitto 8
HU - Ungheria 8
NG - Nigeria 8
TN - Tunisia 8
AE - Emirati Arabi Uniti 7
MY - Malesia 7
CL - Cile 6
IL - Israele 6
MK - Macedonia 6
NZ - Nuova Zelanda 6
PT - Portogallo 6
SA - Arabia Saudita 6
DK - Danimarca 5
JO - Giordania 5
KE - Kenya 5
LT - Lituania 5
PE - Perù 5
RO - Romania 5
BY - Bielorussia 4
EE - Estonia 4
JM - Giamaica 4
LB - Libano 4
AO - Angola 3
AZ - Azerbaigian 3
ET - Etiopia 3
GT - Guatemala 3
PS - Palestinian Territory 3
PY - Paraguay 3
QA - Qatar 3
SI - Slovenia 3
TH - Thailandia 3
AL - Albania 2
BB - Barbados 2
BJ - Benin 2
BO - Bolivia 2
CR - Costa Rica 2
GA - Gabon 2
GE - Georgia 2
HN - Honduras 2
KZ - Kazakistan 2
LU - Lussemburgo 2
LY - Libia 2
NP - Nepal 2
PA - Panama 2
SK - Slovacchia (Repubblica Slovacca) 2
TT - Trinidad e Tobago 2
A1 - Anonimo 1
CD - Congo 1
CG - Congo 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
Totale 12.997
Città #
Ashburn 685
Singapore 555
Dallas 479
Hong Kong 468
Chandler 419
Woodbridge 366
Santa Clara 353
Fairfield 347
Serra 335
Ann Arbor 286
Beijing 238
Milan 210
Shanghai 209
Sofia 196
Houston 182
New York 175
Wilmington 134
Los Angeles 133
Seattle 133
Princeton 115
Cambridge 110
Boardman 109
Munich 93
Hefei 83
Florence 82
Lawrence 81
Pisa 80
Ottawa 74
Seoul 74
Frankfurt am Main 73
Abidjan 71
Livorno 69
Medford 68
Vienna 67
Izmir 66
Helsinki 61
Rome 52
Ogden 50
Bremen 49
Redwood City 48
Nanjing 46
Des Moines 44
Jacksonville 43
Buffalo 41
Dong Ket 40
Lancaster 37
Turku 37
Istanbul 34
São Paulo 32
Redondo Beach 30
Council Bluffs 28
Marseille 27
Nanchang 27
Ho Chi Minh City 26
San Diego 26
London 25
Pune 25
Paris 24
Tokyo 24
Dakar 22
Nuremberg 22
Warsaw 22
Boulder 21
Dearborn 21
Lappeenranta 21
Hanoi 20
Plovdiv 20
Brussels 19
Hyderabad 19
San Jose 19
Amsterdam 16
Chicago 16
Norwalk 16
Brooklyn 15
Lucca 15
Rio de Janeiro 15
Bern 14
Vancouver 14
Chennai 13
Kunming 13
Montreal 13
San Francisco 13
Dublin 12
Jiaxing 12
Nürnberg 12
Orem 12
Toronto 12
Fuzhou 11
Palermo 11
Tashkent 11
Washington 11
Auburn Hills 10
Changsha 10
Düsseldorf 10
Pontedera 10
Poplar 10
Verona 10
Boston 9
Atlanta 8
Barcelona 8
Totale 8.682
Nome #
A breath sampling system assessing the influence of respiratory rate on exhaled breath composition 283
Breath Analysis: Analytical Methodologies and Clinical Applications 282
A snow/firn four-century record of polycyclic aromatic hydrocarbons (PAHs) and polychlorobiphenyls (PCBs) at Talos Dome (Antarctica). 254
Using labelled internal standards to improve needle trap micro-extraction technique prior to gas chromatography/mass spectrometry 240
MS-based targeted profiling of oxylipins in COVID-19: A new insight into inflammation regulation 234
Potentiometric sensor for non invasive lactate determination in human sweat 228
Determination of salivary alpha-amylase and cortisol in psoriatic subjects undergoing the Trier Social Stress Test 220
Release of harmful volatile organic compounds (VOCs) from photo-degraded plastic debris: A neglected source of environmental pollution 219
Comparison of sampling bags for the analysis of volatile organic compounds in breath 214
The Removal of β2-Microglobulin in Spent Dialysate Cannot Be Monitored by Spectrophotometric Analysis 204
A dual mode breath sampler for the collection of the end-tidal and dead space fractions 203
The effect of sampling procedures on the urate and lactate concentration in oral fluid 202
Determination and stability of N-terminal pro-brain natriuretic peptide in saliva samples for monitoring heart failure 198
Determination of volatile organic compounds in exhaled breath of heart failure patients by needle trap micro-extraction coupled with gas chromatography-tandem mass spectrometry 192
A four century firn record of PAHs and PCBs at Talos Dome, Victoria Land (Antartica) 189
Uric acid is the major determinant of absorbance in spent dialysate allowing spectrophotometric evaluation of dialysis dose 186
Multi-Analytical Approach to Characterize the Degradation of Different Types of Microplastics: Identification and Quantification of Released Organic Compounds 182
Spatial and temporal trends of organic pollutants in Antarctica 176
Determination of carbonyl compounds in exhaled breath by on-sorbent derivatization coupled with thermal desorption and gas chromatography-tandem mass spectrometry 175
Pharmacological characterization of the vascular effects of aryl isothiocyanates: Is hydrogen sulfide the real player? 174
Micro-extraction by packed sorbent combined with UHPLC-ESI-MS/MS for the determination of prostanoids and isoprostanoids in dried blood spots 174
Monitoring of warfarin therapy: Preliminary results from a longitudinal pilot study 173
Monitoring breath during oral glucose tolerance tests 172
Determination of biomarkers in oral fluid for monitoring heart failure patients 172
Saliva sampling: Methods and devices. An overview 172
Determination of volatile organic compounds in human breath for monitoring heart failure patients 169
Determination of sevoflurane and isopropyl alcohol in exhaled breath by thermal desorption gas chromatography-mass spectrometry for exposure assessment of hospital staff 168
SALIVA AS A TOOL FOR MONITORING OXIDATIVE STRESS IN SWIMMERS ATHLETES PERFORMING A VO2 CYCLE ERGOMETER TEST 168
Monitoraggio non invasivo di terapie anticoagulanti orali 166
Analysis of isoprostanes in oral fluid using micro extraction by packed sorbent coupled to liquid chromatography-tandem mass spectrometry to monitor oxidative stress in healthy adults performing physical activity 163
Effects of long-term vegan diet on breath composition 161
Sampling bags for breath analysis 159
Influence of sampling on the determination of warfarin and warfarin alcohols in oral fluid 157
Predicting Heart Failure Patient Events by Exploiting Saliva and Breath Biomarkers Information 156
Caratterizzazione chimica dell'espirato umano in pazienti affetti da diabete mediante GC/MS 154
Measurement of Warfarin in the Oral Fluid of Patients Undergoing Anticoagulant Oral Therapy 154
A computational approach for the estimation of heart failure patients status using saliva biomarkers 154
Post-operative elimination of sevoflurane anesthetic and hexafluoroisopropanol metabolite in exhaled breath:pharmacokinetic models for assessing liver function 152
Saliva as a non-invasive tool for monitoring oxidative stress in swimmers athletes performing a VO2max cycle ergometer test 152
Aspetti metodologici del campionamento dell’espirato 151
A non-invasive approach for monitoring patients undergoing anticoagulant therapy 150
Estimation of Heart Failure Patients Medication Adherence through the Utilization of Saliva and Breath Biomarkers and Data Mining Techniques 150
Pervasive sensors for real time monitoring 149
DETERMINATION OF BIOMARKERS IN BREATH AND SALIVA FOR MONITORING HEART FAILURE PATIENTS 144
Diet and other factors affecting the variability of breath composition 141
Determination of carbonyl compounds in exhaled breath by on-sorbent derivatization coupled with thermal desorption and gas chromatography-tandem mass spectrometry 132
A purge and trap method for the analysis of volatile organic compounds in human oral fluid 130
SALIVA AS A TOOL FOR MONITORING OXIDATIVE STRESS IN SWIMMERS ATHLETES PERFORMING A VO2 CYCLE ERGOMETER TEST 130
Determination of anticoagulant drugs and their metabolites in oral fluid and plasma samples by HPLC-Fluorimetry 125
Spectrophotometric measurement of uric acid in spent dialysate for estimating dialysis dose 122
A low-cost internal standard loader for solid-phase sorbing tools 121
Using labelled internal standards to improve needle trap micro-extraction technique prior to gas chromatography/mass spectrometry 121
A non-invasive approach for monitoring patients undergoing anticoagulant therapy 120
Effect of sampling procedures for the chemical characterization of oral fluid in clinical applications 120
Saliva tests: application to drug and health care monitoring 120
Micro extraction by packed sorbent coupled to liquid chromatography-tandem mass spectrometry for the analysis of prostanoids and isoprostanoids in dried blood spots of preterm newborns suffering from patent ductus arteriosus 116
May oral fluid analysis complement INR assay in the prevention of adverse events? 115
Methodological aspects of dried blood spot sampling for the determination of isoprostanoids and prostanoids 113
NEEDLE TRAP MICRO-EXTRACTION: A NEW STRATEGY FOR THE COLLECTION AND PRECONCENTRATION OF BREATH SAMPLES 111
Monitoring urea, creatinine and 2-microglobulin concentrations in spent dialysate by spectrophotometric and spectrofluorimetric measurements 110
Development of an Analytical Procedure for the Quantification of Volatile Compounds in Human Breath 110
Monitoring of warfarin therapy by saliva analysis: an open issue on the way to clinical practice 110
Determination of warfarin and warfarin alcohols in dried blood spots by ultra-high performance liquid chromatography coupled to electrospray ionization-tandem mass spectrometry (UHPLC-ESI-MS/MS) 109
Salivary lipid mediators: Key indexes of inflammation regulation in heart failure disease 108
THE EFFECT OF EXERCISE ON SALIVARY LACTATE, ALPHA-AMYLASE AND URIC ACID IN HEALTHY VOLUNTEERS 107
Salivary lactate and 8-isoprostaglandin F2α as potential non-invasive biomarkers for monitoring heart failure: a pilot study 107
Determination of volatile organic compounds in exhaled breath of heart failure patients by needle trap micro-extraction coupled with gas chromatography-tandem mass spectrometry 106
Influence of sampling on the measured concentration of warfarin and warfarin alcohols in oral fluid 104
Biological studies with comprehensive 2D-GC-HRMS screening: Exploring the human sweat volatilome 102
Determination of peppermint compounds in breath by needle trap micro-extraction coupled with gas chromatography-tandem mass spectrometry 102
A breath sampler prototype to collect end-tidal and dead space fractions 101
Spectrophotometric and spectrofluorimetric analysis of spent dialysate should allow monitoring of dialysis adequacy even if urea concentrations cannot be determined by these methods 100
Determination of warfarin and warfarin alcohols in oral fluid and plasma samples for monitoring patients undergoing anticoagulant therapy 99
Stability of volatile organic compounds in sorbent tubes following SARS-CoV-2 inactivation procedures 98
Type-specific inflammatory responses of vascular cells activated by interaction with virgin and aged microplastics 98
Development of a high-throughput liquid chromatography-tandem mass spectrometry platform for the determination of intact natriuretic peptides in human plasma 97
Volatile Compounds in Human Breath During Oral Glucose Tolerance Test 97
Correlation between warfarin salivary concentration and anticoagulant effect 96
Determination of anticoagulant drugs and their metabolites in oral fluid: strategies for sample collection 96
Breath analysis combined with cardiopulmonary exercise testing and echocardiography for monitoring heart failure patients: the AEOLUS protocol 95
Correlazione tra contenuto salivare di farmaci anticoagulanti in pazienti trombotici ed effetto anticoagulante 90
Advances in breath and saliva analysis 90
Sport in town: The smart healthy env project, a pilot study of physical activity with multiparametric monitoring 90
null 89
Determination of bound and unbound warfarin and its metabolites in human plasma 87
Determinazione del warfarin in campioni di saliva e plasma raccolti da pazienti in terapia anticoagulante 86
Pharmacokinetic models of post-operative elimination of sevoflurane anesthetic and hexafluoroisopropanol metabolite as measured in exhaled breath 86
Determination of volatile organic compounds in human breath samples for heart failure monitoring 83
A sampler prototype for the simultaneous collection of exhaled air and breath condensate 81
Monitoring urea, creatinine and 2-microglobulin concentrations in spent dialysate by spectrophotometric and spectrofluorimetric measurements 73
Decoding the Challenges: navigating Intact Peptide Mass Spectrometry-Based Analysis for Biological Applications 69
null 69
The effect of SARS-CoV-2 variants on the plasma oxylipins and PUFAs of COVID-19 patients 69
Determination of volatile organic compounds in human breath samples for heart failure monitoring 55
A MEPS-UHPLC-MS/MS analytical platform to detect isoprostanoids and specialized pro-resolving mediators in the urinary extracellular vesicles of mountain ultramarathon runners 48
Dried blood spot analysis of long-chain polyunsaturated fatty acids and oxylipins for monitoring heart failure 12
HiSorb sorptive extraction for determining salivary short chain fatty acids and hydroxy acids in heart failure patients 11
Totale 13.272
Categoria #
all - tutte 37.752
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.752


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021491 0 0 0 0 0 0 64 50 145 81 41 110
2021/20221.060 24 56 26 58 160 120 40 66 37 47 117 309
2022/20231.535 194 239 119 172 124 170 12 102 276 17 93 17
2023/20241.128 92 94 133 72 134 191 57 38 35 74 80 128
2024/20253.291 42 108 66 189 219 336 397 169 303 415 410 637
2025/20262.433 247 467 532 356 433 376 22 0 0 0 0 0
Totale 13.272